As personalised treatments become widespread, the importance of biomarkers in everyday medical care is growing day by day
Auxiliis Biomarker aims to identify, test and validate biomarkers that will become cornerstones of medicine, and to bring them to the international market in accordance with professional protocols. In doing so, it provides both doctors and patients with information about the status of a disease.
Our first product is the MMP-3 biomarker, which is key to understanding, diagnosing and treating rheumatoid arthritis – for both specialists and patients.